Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocol
Introduction Idiopathic pulmonary fibrosis (IPF) is a rare, chronic and progressive lung disease with a significant impact on patients’ quality of life. While much research has focused on disease mechanisms and treatment efficacy, limited attention has been paid to the landscape, unmet needs, patien...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/8/e098770.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849770809542836224 |
|---|---|
| author | Bo Yuan Ning Liu Ping Ji Hongling Chu Siyan Zhan Xiaohan Xu Yue Zhang Wenqiang Li Xiang Fang Zhen Huang Yanling Ding Ning Shen Yunxian Zhou Xi Zhan Xiaoxi Lu Bixuan Yan |
| author_facet | Bo Yuan Ning Liu Ping Ji Hongling Chu Siyan Zhan Xiaohan Xu Yue Zhang Wenqiang Li Xiang Fang Zhen Huang Yanling Ding Ning Shen Yunxian Zhou Xi Zhan Xiaoxi Lu Bixuan Yan |
| author_sort | Bo Yuan |
| collection | DOAJ |
| description | Introduction Idiopathic pulmonary fibrosis (IPF) is a rare, chronic and progressive lung disease with a significant impact on patients’ quality of life. While much research has focused on disease mechanisms and treatment efficacy, limited attention has been paid to the landscape, unmet needs, patient experiences and quality of life. Understanding these aspects through the patient journey is essential for developing patient-centred therapeutic strategies. Therefore, this study aims to explore the status of diagnosis, treatment, the unmet needs and patient experiences of IPF in China through an analysis of the patient journey using mixed methods research. The findings in this study provide valuable insights to guide drug development, optimise clinical decision-making and support health technology assessments.Methods and analysis An exploratory sequential mixed methods design will be used in two phases. In the qualitative phase, 50 patients with IPF and 15 experienced physicians will be recruited to complete in-depth interviews. Patient journey and unmet medical needs will be the focus of data collection. Based on the findings of the qualitative study, a structured questionnaire will be developed for the subsequent quantitative study. Data will be collected from 245 patients with IPF to quantitatively analyse critical points in the patient journey, quality of life, unmet needs and treatment expectations. The integration of patient experience data into the drug/intervention development lifecycle in this mixed methods research will enhance the relevance of IPF interventions, optimising disease management strategies and improving patient health outcomes.Ethics and dissemination The study has been approved by the Peking University Third Hospital Medical Science Research Ethics Committee (2024-188-02). Prior to the study, study information will be provided, and consent will be obtained. Findings in this study will be disseminated in peer-reviewed publications and conferences.Trial registration number NCT06629623. |
| format | Article |
| id | doaj-art-3223a42f5a3a4a1281803fccd885131a |
| institution | DOAJ |
| issn | 2044-6055 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-3223a42f5a3a4a1281803fccd885131a2025-08-20T03:02:52ZengBMJ Publishing GroupBMJ Open2044-60552025-08-0115810.1136/bmjopen-2025-098770Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocolBo Yuan0Ning Liu1Ping Ji2Hongling Chu3Siyan Zhan4Xiaohan Xu5Yue Zhang6Wenqiang Li7Xiang Fang8Zhen Huang9Yanling Ding10Ning Shen11Yunxian Zhou12Xi Zhan13Xiaoxi Lu14Bixuan Yan15Department of General Practice, West China Hospital of Sichuan University, Chengdu, ChinaSchool of Nursing, Peking University, Beijing, ChinaClinical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, ChinaResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, ChinaResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing, ChinaClinical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, ChinaResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, ChinaDepartment of General Internal Medicine, Sichuan University West China Second University Hospital, Chengdu, ChinaPeking University Cancer Hospital, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, ChinaSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital Capital Medical University, Beijing, ChinaDepartment of Computer Science and Technology, Southern University of Science and Technology, Shenzhen, ChinaResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, ChinaIntroduction Idiopathic pulmonary fibrosis (IPF) is a rare, chronic and progressive lung disease with a significant impact on patients’ quality of life. While much research has focused on disease mechanisms and treatment efficacy, limited attention has been paid to the landscape, unmet needs, patient experiences and quality of life. Understanding these aspects through the patient journey is essential for developing patient-centred therapeutic strategies. Therefore, this study aims to explore the status of diagnosis, treatment, the unmet needs and patient experiences of IPF in China through an analysis of the patient journey using mixed methods research. The findings in this study provide valuable insights to guide drug development, optimise clinical decision-making and support health technology assessments.Methods and analysis An exploratory sequential mixed methods design will be used in two phases. In the qualitative phase, 50 patients with IPF and 15 experienced physicians will be recruited to complete in-depth interviews. Patient journey and unmet medical needs will be the focus of data collection. Based on the findings of the qualitative study, a structured questionnaire will be developed for the subsequent quantitative study. Data will be collected from 245 patients with IPF to quantitatively analyse critical points in the patient journey, quality of life, unmet needs and treatment expectations. The integration of patient experience data into the drug/intervention development lifecycle in this mixed methods research will enhance the relevance of IPF interventions, optimising disease management strategies and improving patient health outcomes.Ethics and dissemination The study has been approved by the Peking University Third Hospital Medical Science Research Ethics Committee (2024-188-02). Prior to the study, study information will be provided, and consent will be obtained. Findings in this study will be disseminated in peer-reviewed publications and conferences.Trial registration number NCT06629623.https://bmjopen.bmj.com/content/15/8/e098770.full |
| spellingShingle | Bo Yuan Ning Liu Ping Ji Hongling Chu Siyan Zhan Xiaohan Xu Yue Zhang Wenqiang Li Xiang Fang Zhen Huang Yanling Ding Ning Shen Yunxian Zhou Xi Zhan Xiaoxi Lu Bixuan Yan Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocol BMJ Open |
| title | Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocol |
| title_full | Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocol |
| title_fullStr | Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocol |
| title_full_unstemmed | Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocol |
| title_short | Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocol |
| title_sort | patient journey and quality of life for patients with idiopathic pulmonary fibrosis ipflife in china a sequential exploratory mixed methods research protocol |
| url | https://bmjopen.bmj.com/content/15/8/e098770.full |
| work_keys_str_mv | AT boyuan patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT ningliu patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT pingji patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT honglingchu patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT siyanzhan patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT xiaohanxu patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT yuezhang patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT wenqiangli patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT xiangfang patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT zhenhuang patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT yanlingding patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT ningshen patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT yunxianzhou patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT xizhan patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT xiaoxilu patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol AT bixuanyan patientjourneyandqualityoflifeforpatientswithidiopathicpulmonaryfibrosisipflifeinchinaasequentialexploratorymixedmethodsresearchprotocol |